People with vasculitis can receive the New Crown vaccine when their condition is stable. If the vasculitis is in the acute stage or the condition is not yet stable, and they are currently receiving hormonal and immunosuppressive therapy, the New Crown vaccine is not recommended.
Vasculitis is a disease of the immune system and can manifest as inflammation and necrosis of the walls of multi-vesseled blood vessels and perivascular tissues. Treatment is based on hormones and immunosuppressive drugs. Whether or not vasculitis can be vaccinated with the New Crown Vaccine depends mainly on whether or not the disease is stabilized.
If the condition of vasculitis has been stabilized, with no related symptoms such as fever, fatigue, etc., and related inflammatory indexes such as blood sedimentation and C-reactive protein are within the normal range, and there is no further application of medication at the present time, it is possible to receive the new crown vaccine.
If the disease is in the acute stage or not yet stable, currently receiving hormone and immunosuppressant treatment, it is recommended to postpone the new crown vaccination.
Patients with vasculitis need to go to the Rheumatology Department for a full assessment of their condition before receiving the vaccine and follow the doctor’s advice on whether or not to receive the vaccine.